EU reviews J&J COVID-19 vaccine for blood clots

CGTN

text

Europe's drugs regulator said on Friday it was looking into Johnson Johnson's shot over reports of rare blood clots.

Four serious cases of rare blood clots with low platelets, one of which was fatal, have been reported after inoculation with JJ's vaccine from its Janssen unit, the European Medicines Agency (EMA) said.

However, the EMA has said that "at this stage, it is not yet clear whether there is a causal association" between the vaccines and the reported conditions.